boston.com Your Life your connection to The Boston Globe
White Coat Notes: News from the Boston-area medical community
Comments
Send your comments and tips to whitecoat@globe.com
Categories


Blogger
Elizabeth Cooney is a health reporter for the Worcester Telegram & Gazette.
Contributors
Boston Globe Health and Science staff:
Scott Allen
Alice Dembner
Carey Goldberg
Liz Kowalczyk
Stephen Smith
Colin Nickerson
Beth Daley
Karen Weintraub, Deputy Health and Science Editor, and Gideon Gil, Health and Science Editor.
 Short White Coat blogger Ishani Ganguli
 Short White Coat blogger Jennifer Srygley
Week of: November 11
Week of: November 4
Week of: October 28
Week of: October 21
Week of: October 14
Week of: October 7

« Beth Israel Deaconess names research operations head | Main | Coming Sunday: A trusted doctor's sex change tests his patients »

Friday, August 10, 2007

Today's Globe: shots in abortions, Myozyme doses, Alnylam-US pact, heartburn drugs

In response to the Supreme Court decision upholding the Partial-Birth Abortion Ban Act, many abortion providers in Boston and around the country have adopted a defensive tactic. To avoid any chance of partially delivering a live fetus, they are injecting fetuses with lethal drugs before procedures.

Genzyme Corp. is asking adult US patients with Pompe disease to skip two doses of its drug Myozyme in coming months so the Cambridge company can stretch supplies until regulators allow the treatment to be distributed from a new manufacturing plant.

Alnylam Pharmaceuticals Inc. of Cambridge said yesterday that it has been awarded a $38.6 million government contract to develop RNAi therapeutics for biological threats.

The popular heartburn drugs Prilosec and Nexium don't appear to spur heart problems, according to preliminary results of US and Canadian probes disclosed yesterday.

Posted by Elizabeth Cooney at 06:39 AM
Sponsored Links